By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



6340 Sequence Drive

San Diego  California  92121  U.S.A.
Phone: 858-200-0200 Fax: 858-200-0201


Company News
DexCom (DXCM) Schedules Second Quarter 2017 Earnings Release And Conference Call For August 1, 2017 At 4:30 P.M. Eastern Time 6/20/2017 11:14:39 AM
DexCom (DXCM) Release: New Study Shows Adults With Type 1 And Type 2 Diabetes On Multiple Daily Injections (MDI) Benefit From CGM 6/9/2017 7:25:37 AM
DexCom (DXCM) To Add Ambulatory Glucose Profile (AGP) To Dexcom CLARITY 6/8/2017 8:27:33 AM
DexCom (DXCM) Prices Offering Of $350 Million Of 0.75% Convertible Senior Notes 5/9/2017 10:21:45 AM
DexCom (DXCM) Reports First Quarter 2017 Financial Results 5/3/2017 9:30:59 AM
DexCom (DXCM) Release: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM For All People With Diabetes On Intensive Insulin Therapy 3/24/2017 8:42:34 AM
DexCom (DXCM) Appoints Richard Collins To Board Of Directors 3/13/2017 8:31:07 AM
DexCom (DXCM) Release: Company Announces Publication Of Key Study In JAMA Demonstrating The Value Of CGM In Reducing A1C And Hypoglycemia In Diabetes Patients On Injection Therapy 1/25/2017 9:08:50 AM
DexCom (DXCM) Release: Schedules Fourth Quarter And Full Year 2016 Earnings Release And Conference Call For February 28, 2017 At 4:30 P.M. Eastern Time 1/23/2017 8:16:06 AM
DexCom (DXCM) Release: The Launch Of Dexcom Canada Will Reshape How Canadians Living With Diabetes Access And Use Continuous Glucose Monitoring 1/11/2017 8:11:00 AM